biOasis Technologies Ord Shs V.BTI.H

Primary Symbol: BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by neinsteinon Jun 18, 2014 10:28am

187 Views

Post# 22670559

RE:Nice run

Don't be too quick to ascribe all or even a meaningful amount of that buying to Gale Capital. I can assure you there were plenty of other existing shareholders adding to their postions in the past few weeks. Shareholders brought into this story long ago by previous (unfairly maligned) IR firms.

Bullboard Posts

Bitcoin Well increases reserve amid strong subscriber growth